Ms. Michelson has served as Senior Vice President of Developmental Operations since May 2023. Prior to joining IGM, she served as Senior Vice President of Clinical Operations at Medpace, a global drug, biologic and medical device clinical research organization. Ms. Michelson has also held numerous global leadership roles in clinical trial management and operations at Medtronic, Abraxis Bioscience, PPD and Amgen. Her early operations and drug development experience were formed at Quintiles and Ionis Pharmaceuticals (formerly Isis Pharmaceuticals) where she developed her safety and clinical trial management interests. Ms. Michelson started off her career in oncology and critical care nursing. She holds a B.S. in Nursing from the Johns Hopkins University School of Nursing.